Tax Breaks for Big Pharma on Top of Unreasonable Price Hikes
Big Pharma’s claim that it is hard pressed to find cash for R&D spending needs to be taken with a fistful of salt.
Read more...Big Pharma’s claim that it is hard pressed to find cash for R&D spending needs to be taken with a fistful of salt.
Read more...As counterintuitive as it seems, reducing the “digital divide” may not be the plus its advocates assumed it was, if the UK experience is any guide.
Read more...Get a cup of coffee. This is a deep dive into how Bitcoin works from a payment systems perspective, and why the failure of promoters and journalists to look at it in those terms has led them to greatly overestimate its significance.
Read more...Is the professional about to go the way of the dodo bird?
Read more...What makes bureaucracies innovative?
Read more...Richter describes what it’s like as a publisher to be subject to the vagaries of Google Adsense.
Read more...How can recent technical change could both be a major source of dis-employment and not be associated with productivity improvement?
Read more...An intriguing comparison of how the Internet of Things is being sold in the US and Japan.
Read more...Pfizer whines about needing higher drug prices, when rather than investing, it has spent over 100% of its profits on stock buybacks and dividends.
Read more...Consideration of climate change has been almost totally missing from discussions about the future of work. What happens when you include it?
Read more...IBM discovers that financial engineering bites back.
Read more...How Steve Jobs’ successes were government sponsored enterprises.
Read more...Even with the cost efficiency of renewables being much higher than many realize, major energy buyers don’t act as if the oil age is ending soon.
Read more...An in-depth look at the US’s big-ticket intelligence apparatus that can’t shoot straight in the Middle East. A bug or a feature?
Read more...Why the excuses to do nothing or too little on the climate change front don’t hold up to serious scrutiny.
Read more...